Covid-19, Acute Myocardial Infarctions and Strokes in France (COVUSI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04542083|
Recruitment Status : Not yet recruiting
First Posted : September 9, 2020
Last Update Posted : September 9, 2020
The COVID-19 pandemic has had dramatic effects on health systems and on non-COVID health care.
Using French inpatient claims data and retrospectively collected clinical data, the investigators will assess the changes in hospital admissions for acute cardiovascular and neurovascular conditions in France during and after the national lockdown.
|Condition or disease|
|COVID-19 Acute Cardiovascular Condition Acute Neurovascular Condition Stroke Acute Myocardial Infarction|
|Study Type :||Observational|
|Estimated Enrollment :||4000 participants|
|Official Title:||Impact of COVID-19 on Unplanned Admissions for Acute Cardiovascular and Neurovascular Conditions in France|
|Estimated Study Start Date :||December 1, 2020|
|Estimated Primary Completion Date :||June 1, 2021|
|Estimated Study Completion Date :||June 30, 2021|
Admissions from January to December 2020
Admissions from January 2018 to December 2019
- Daily number of admissions for acute cardio- and neurivascular conditions in France. [ Time Frame: 1 day ]Daily number of admissions for acute cardio- and neurivascular conditions in France.
- Specific mortality rate. [ Time Frame: 1 day ]Specific mortality rate.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04542083
|Contact: Grégoire Mercier, PU PH||4 67 33 91 09 ext firstname.lastname@example.org|
|Montpellier, France, 34295|
|Principal Investigator:||Grégoire Mercier, PU PH||University Hospital, Montpellier|